Bleeding Risk Following Percutaneous Coronary Intervention in Patients with Diabetes Prescribed Dual Anti-platelet Therapy

BACKGROUND: Patients with diabetes (DM) experience higher rates of in-stent restenosis and greater benefit from DES implant at the time of PCI, necessitating prolonged dual anti-platelet therapy (DAPT). While DAPT reduces risk of ischemic events post-PCI, it also increases risk of bleeding. Whether...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am Heart J
Main Authors: Grodzinsky, Anna, Arnold, Suzanne V., Wang, Tracy Y., Sharma, Praneet, Gosch, Kensey, Jones, Philip G., Bhatt, Deepak L., Steg, Philippe Gabriel, McGuire, Darren K., Cohen, David J., Spertus, John A., Chhatriwalla, Adnan K., Lind, Marcus, Graham, Garth, Kosiborod, Mikhail
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5357237/
https://ncbi.nlm.nih.gov/pubmed/27914490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2016.09.010
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares